Update: Google Ad-Tech Remedy Timeline Is Years Away, Not 60 Days

Full analysis

What's new since we last covered this: Judge's timeline clarified: remedies implementation delayed to 2028, not 2026.

Everyone's clock is wrong on the Google ad-tech remedy. The coverage that told you publishers would see changes "before Thanksgiving" is off by roughly two years. There is no final judgment yet. Judge Leonie Brinkema ordered Google and the DOJ to draft one by October 2, 2026. The decree only starts running 60 days after the court enters that draft, and both sides will fight over definitions first. Add the 12 to 15 month integration timelines for Prebid and AdX, and publishers realistically feel nothing operational until around 2028.

That timing matters less than the shape of what's coming. The remedy is confined to open-web display: publisher ad servers and ad exchanges. Video, CTV, and in-app are excluded or treated specially. DV360, Google's demand-side buying platform for agency trading desks, walked away untouched because the government never proved its role at trial. The DOJ's plan to make Google fund publisher migration through an escrow account got rejected. And the language meant to stop Google inventing new workarounds got mostly stripped out.

So we have a worldwide decree, aimed at the slowest-growing corner of digital advertising, arriving two years late, with no teeth against future tactics.

The Market Analyst. The relief rally in independent supply-side names was built on a misread. Magnite and PubMatic are the two public sell-side ad-tech firms that route open-web display inventory, and they got sentiment bumps on the idea that a broken-up Google reopens publisher relationships. But that relief lands in 2028, in the one inventory category that's shrinking. In plain terms: investors bid up the companies that would supposedly win, without checking that the prize is a shrinking pie handed over years from now. Google's stock is insulated. DV360 intact, CTV and video out of scope, and a clock that only starts after a contested draft. If you're long the SSP-relief story, you're long a narrow win with a long fuse.

The Skeptic. Steelman the "Google loses" case and it collapses. For this to be a real defeat, open-web display would have to be where the money is going. It isn't. CPMs there are compressing and budgets are migrating to CTV and retail media. The publishers who'd benefit from AdX competition are already diversifying or dying. No anti-circumvention teeth means Google adapts at leisure. A decade of litigation produced a geographically broad, commercially narrow decree that skips the three fastest-growing inventory types. Calling this a Google loss is generous. The antitrust story wants a villain's comeuppance. The decree doesn't deliver one.

The Operator. Reset your roadmap. Supply ops leads, yield managers, and programmatic directors who parked publisher-side decisions "pending the ruling" have been waiting on a 2025 event that was never happening. Your real operational horizon is 2028 at the earliest. Meanwhile DV360 faces zero restrictions, so agency trading desks keep their workflow exactly as is, and open-web display yield teams get no structural relief before 2027. The budgets you actually chase, in CTV and in-app, sit entirely outside the decree. Anyone who told their CMO that Google's grip was "about to break" owes them a corrected memo this quarter.

The Strategist. The damage isn't the eventual remedy. It's the market structure that hardens while everyone waits. Google keeps full DV360 leverage over the buy side, so the part of its moat that touches agency spend never gets tested. The confined remedy perimeter is the part of the market losing share every quarter. Any structural edge for independent SSPs shows up in 2028, in open-web display, right as that segment keeps bleeding to CTV and retail media. The puck is not going to open-web display. Google's competitors banking on antitrust to reopen publisher doors should be building CTV and in-app supply paths now.

Where they disagree. The Operator says reset the calendar and wait it out. The Strategist says waiting is the trap. Both agree the timeline slipped to 2028, but the Strategist's point is that the market keeps calcifying in Google's favor during the delay, so "wait and see" is itself a losing move. The second split is about whether the remedy matters at all. The Skeptic argues open-web display is too small to care about even if Google is fully constrained. The Market Analyst agrees on the economics but notes the trade still exists: fade the names that rallied on a misunderstanding.

What this hinges on. Two facts do the work. First, the decree covers open-web display only, and that's the shrinking segment. Second, nothing binds Google's buy-side platform or its future workarounds. If both hold, the remedy is real but slow and narrow, and the near-term action is entirely in coverage correction and repriced sentiment, not in operational change. The council leans hard one way: the "Google's dominance is about to break" narrative is wrong on timing and wrong on scope.

Prediction: Neither Magnite nor PubMatic will attribute a material revenue increase to the Google ad-tech remedy in any earnings call through Q4 2027 reporting (roughly February 2028), because no operational change to AdX or Prebid integration will have taken effect by then.

Confidence: High. The procedural clock alone rules out operational change before 2028.

Why: There is no final judgment yet; Brinkema ordered the parties to draft one by October 2, 2026, and the decree only takes effect 60 days after the court enters that contested draft. Layer on the 12 to 15 month integration timelines for Prebid and AdX and the earliest operational change lands around 2028, past the Q4 2027 reporting window. For the opposite to happen, both the definitional disputes and the phased implementation would have to resolve far faster than any party has proposed, and Google has every incentive to slow-walk both. The relief priced into these two independent sell-side ad-tech names is betting on a change that cannot physically arrive inside the window.

Revisit by 2028-02-28: We're right if, through Q4 2027 earnings calls, neither Magnite nor PubMatic names the Google remedy as a driver of realized revenue growth from live AdX or Prebid integration changes. We're wrong if either reports actual revenue gains tied to an in-effect remedy change to Google's ad exchange or server before that date.